Skip to Main Content

Advertisement

Umbrella Alt Text
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 4, Issue 6
1 June 1998
Issue Cover
All Issues
ISSN 1078-0432
EISSN 1557-3265
Issue Sections

Advances in Brief

Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.
G Zalcman; B Schlichtholz; J Trédaniel; T Urban; R Lubin; I Dubois; B Milleron; A Hirsch; T Soussi
View articletitled, Monitoring of p53 autoantibodies in lung cancer during therapy: relationship to response to treatment.
Open the PDF for in another window
Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
B Holm; M Sehested; P B Jensen
View articletitled, Improved targeting of brain tumors using dexrazoxane rescue of topoisomerase II combined with supralethal doses of etoposide and teniposide.
Open the PDF for in another window

Research Articles

Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
H Porte; J P Triboulet; L Kotelevets; F Carrat; S Prévot; B Nordlinger; Y DiGioia; A Wurtz; P Comoglio; C Gespach; E Chastre
View articletitled, Overexpression of stromelysin-3, BM-40/SPARC, and MET genes in human esophageal carcinoma: implications for prognosis.
Open the PDF for in another window
Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.
I V Boiko; M F Mitchell; W Hu; D K Pandey; P Mathevet; A Malpica; W N Hittelman
View articletitled, Epidermal growth factor receptor expression in cervical intraepithelial neoplasia and its modulation during an alpha-difluoromethylornithine chemoprevention trial.
Open the PDF for in another window
The expression of drug resistance gene products during the progression of human prostate cancer.
G F Sullivan; P S Amenta; J D Villanueva; C J Alvarez; J M Yang; W N Hait
View articletitled, The expression of drug resistance gene products during the progression of human prostate cancer.
Open the PDF for in another window
4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.
R K Narla; X P Liu; D E Myers; F M Uckun
View articletitled, 4-(3'-Bromo-4'hydroxylphenyl)-amino-6,7-dimethoxyquinazoline: a novel quinazoline derivative with potent cytotoxic activity against human glioblastoma cells.
Open the PDF for in another window
Analysis of DNA mismatch repair proteins in human medulloblastoma.
S E Lee; S P Johnson; L P Hale; J Li; N Bullock; H Fuchs; A Friedman; R McLendon; D D Bigner; P Modrich; H S Friedman
View articletitled, Analysis of DNA mismatch repair proteins in human medulloblastoma.
Open the PDF for in another window
Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
P C Caron; L Dumont; D A Scheinberg
View articletitled, Supersaturating infusional humanized anti-CD33 monoclonal antibody HuM195 in myelogenous leukemia.
Open the PDF for in another window
Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.
P R Hutson; K D Tutsch; R Rago; R Arzoomanian; D Alberti; M Pomplun; D Church; R Marnocha; A L Cheng; N Kehrli; G Wilding
View articletitled, Renal clearance, tissue distribution, and CA-125 responses in a phase I trial of suramin.
Open the PDF for in another window
Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
N A Rizvi; J L Marshall; E Ness; J Yoe; G M Gill; J A Truglia; G R Loewen; D Jaunakais; E H Ulm; M J Hawkins
View articletitled, Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
Open the PDF for in another window
Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
A D Elias; C Wheeler; L J Ayash; G Schwartz; J Ibrahim; L Mills; M McCauley; N Coleman; D Warren; L Schnipper; K H Antman; B A Teicher; E Frei, 3rd
View articletitled, Dose escalation of the hypoxic cell sensitizer etanidazole combined with ifosfamide, carboplatin, etoposide, and autologous hematopoietic stem cell support.
Open the PDF for in another window
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
E Warner; D Hedley; I Andrulis; R Myers; M Trudeau; D Warr; K I Pritchard; M Blackstein; P E Goss; E Franssen; K Roche; S Knight; S Webster; R A Fraser; S Oldfield; W Hill; R Kates
View articletitled, Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen.
Open the PDF for in another window
A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
L A Hammond; J R Eckardt; R Ganapathi; H A Burris; G A Rodriguez; S G Eckhardt; M L Rothenberg; G R Weiss; J G Kuhn; S Hodges; D D Von Hoff; E K Rowinsky
View articletitled, A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide.
Open the PDF for in another window
Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
N Boku; K Chin; K Hosokawa; A Ohtsu; H Tajiri; S Yoshida; T Yamao; H Kondo; K Shirao; Y Shimada; D Saito; T Hasebe; K Mukai; S Seki; H Saito; P G Johnston
View articletitled, Biological markers as a predictor for response and prognosis of unresectable gastric cancer patients treated with 5-fluorouracil and cis-platinum.
Open the PDF for in another window
Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
K Mise; S Tashiro; S Yogita; D Wada; M Harada; Y Fukuda; H Miyake; M Isikawa; K Izumi; N Sano
View articletitled, Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
Open the PDF for in another window
Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
T Shibusa; N Shijubo; S Abe
View articletitled, Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
Open the PDF for in another window
Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
H Yu; M A Levesque; G M Clark; E P Diamandis
View articletitled, Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
Open the PDF for in another window
p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
W P Bennett; W S el-Deiry; W L Rush; D G Guinee, Jr; A N Freedman; N E Caporaso; J A Welsh; R T Jones; A Borkowski; W D Travis; M V Fleming; V Trastek; P C Pairolero; H D Tazelaar; D Midthun; J R Jett; L A Liotta; C C Harris
View articletitled, p21waf1/cip1 and transforming growth factor beta 1 protein expression correlate with survival in non-small cell lung cancer.
Open the PDF for in another window
Motility related protein 1 (MRP1/CD9) expression in colon cancer.
M Mori; K Mimori; T Shiraishi; M Haraguchi; H Ueo; G F Barnard; T Akiyoshi
View articletitled, Motility related protein 1 (MRP1/CD9) expression in colon cancer.
Open the PDF for in another window
Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
J Kos; H J Nielsen; M Krasovec; I J Christensen; N Cimerman; R W Stephens; N Brünner
View articletitled, Prognostic values of cathepsin B and carcinoembryonic antigen in sera of patients with colorectal cancer.
Open the PDF for in another window
Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
K Sonoda; T Kaku; T Kamura; M Nakashima; T Watanabe; H Nakano
View articletitled, Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasias.
Open the PDF for in another window
CD28, a marker associated with tumoral expansion in multiple myeloma.
N Robillard; G Jego; C Pellat-Deceunynck; D Pineau; D Puthier; M P Mellerin; S Barillé; M J Rapp; J L Harousseau; M Amiot; R Bataille
View articletitled, CD28, a marker associated with tumoral expansion in multiple myeloma.
Open the PDF for in another window
Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
T Yamada; S Nakamori; H Ohzato; S Oshima; T Aoki; N Higaki; K Sugimoto; K Akagi; Y Fujiwara; I Nishisho; M Sakon; M Gotoh; M Monden
View articletitled, Detection of K-ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: correlation with clinicopathological features.
Open the PDF for in another window
Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma.
D W Dexter; R K Reddy; K G Geles; S Bansal; M A Myint; A Rogakto; J C Leighton; L J Goldstein
View articletitled, Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma.
Open the PDF for in another window
Flow cytometric DNA analyses of benign breast lesions detected by screening mammography.
P C Stomper; J R DeBloom, 2nd; R M Budnick; C C Stewart
View articletitled, Flow cytometric DNA analyses of benign breast lesions detected by screening mammography.
Open the PDF for in another window
Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents.
E A Neuwelt; P A Barnett; C I McCormick; L G Remsen; R A Kroll; G Sexton
View articletitled, Differential permeability of a human brain tumor xenograft in the nude rat: impact of tumor size and method of administration on optimizing delivery of biologically diverse agents.
Open the PDF for in another window
The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
L F Barr; S E Campbell; P Tamez; R A Casero, Jr
View articletitled, The growth inhibitory effect of N1,N12-bis(ethyl)spermine in small cell lung cancer cells is maintained in cells expressing the c-myc and Ha-ras oncogenes.
Open the PDF for in another window
Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance.
C Dumontet; F Bodin; Y Michal
View articletitled, Potential interactions between antitubulin agents and temperature: implications for modulation of multidrug resistance.
Open the PDF for in another window
Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model.
D M Vail; R Chun; D H Thamm; L D Garrett; A J Cooley; J E Obradovich
View articletitled, Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model.
Open the PDF for in another window
Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status.
M Milas; D Yu; D Sun; R E Pollock
View articletitled, Telomerase activity of sarcoma cell lines and fibroblasts is independent of p53 status.
Open the PDF for in another window

Advertisement

Breaking
FDA Bans Red Dye No. 3 in Food
AbbVie Inks Deal for T-Cell Engager
GSK Buys Gastrointestinal-Focused Biopharma
View more recent articles
Latest News
Structural Variants Increase Risk of Pediatric Cancers
South Asian Scholars Urge Action on Cancer Inequities
Greater Certainty of Survival Valued Over Speedier Drug Access
View more recent articles
Research Watch
The Zinc-Binding Cysteine Proteome Comprises Targetable Cancer Vulnerabilities
Engineered Focal Oncogene Amplifications Drive Transformation and Progression
Glycolysis Dictates Response to Fasting-Mimicking Diet in Breast Cancer
View more recent articles

NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.

  • Online ISSN 1557-3265
  • Print ISSN 1078-0432

AACR Journals

 

 

  • Copyright © 2025 by the American Association for Cancer Research.
Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.
Accept